of 75+ adults died within a year of an RSV-associated hospitalisation
92%
of all RSV hospitalisations in the EU were observed in elderly adults (65+)
hMPV (Human Metapneumovirus)
36%
of YoY increase in hMPV-positive tests in March 23’ (US)
40%
of all HMPV-infected 50+ adults develop pneumonitis
RSV and hMPV may cause bronchitis and pneumonia, especially among children and elderly adults. nCage is developing a combo vaccine to help combat both viruses.
.svg)
.svg)
.svg)